Pharmaceutical Impurity Profiling: Simple, Confident Analysis with New GC-MS Technology
07 Dec 2015
In this webinar we will discuss how to overcome the challenges encountered in pharmaceutical intermediate impurity analysis, and how to deliver a new degree of confidence in the identification of unknown volatile and semi-volatile impurities. Hear from scientists at pharmaceutical company AstraZeneca who will evaluate the latest in GC-MS technology for profiling of API and production intermediate impurities. We will present examples of real-world use and results when utilizing this new technology for pharmaceutical impurity profiling.
Thermo Fisher Scientific
- The challenges faced with pharmaceutical API and formulation impurity analysis.
- The latest in GC-MS technology that delivers confident identification of unknown impurities through exceptional mass accuracy and resolution.
- The latest software tools for automated identification of unknowns.